Market Closed -
Hong Kong S.E.
04:08:16 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
1.16
HKD
|
+1.75%
|
|
+1.75%
|
-21.09%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
486.3
|
555.8
|
466.1
|
923.3
|
1,682
|
1,162
|
Enterprise Value (EV)
1 |
530.2
|
629.8
|
558.2
|
851.7
|
1,235
|
546.6
|
P/E ratio
|
-7.93
x
|
25.8
x
|
4.92
x
|
2.43
x
|
1.93
x
|
5.52
x
|
Yield
|
-
|
-
|
4.62%
|
15%
|
14.6%
|
8.83%
|
Capitalization / Revenue
|
0.41
x
|
0.4
x
|
0.34
x
|
0.36
x
|
0.48
x
|
0.56
x
|
EV / Revenue
|
0.45
x
|
0.46
x
|
0.41
x
|
0.33
x
|
0.35
x
|
0.26
x
|
EV / EBITDA
|
10.8
x
|
3.84
x
|
3.85
x
|
1.26
x
|
0.88
x
|
1.36
x
|
EV / FCF
|
253
x
|
19.8
x
|
-2.08
x
|
8.78
x
|
3.04
x
|
1.4
x
|
FCF Yield
|
0.4%
|
5.06%
|
-48%
|
11.4%
|
32.9%
|
71.6%
|
Price to Book
|
0.38
x
|
0.43
x
|
0.34
x
|
0.53
x
|
0.7
x
|
0.48
x
|
Nbr of stocks (in thousands)
|
851,954
|
851,954
|
851,954
|
851,954
|
869,418
|
869,418
|
Reference price
2 |
0.5708
|
0.6524
|
0.5471
|
1.084
|
1.934
|
1.336
|
Announcement Date
|
4/18/19
|
4/23/20
|
4/21/21
|
4/22/22
|
4/26/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,179
|
1,381
|
1,359
|
2,585
|
3,521
|
2,080
|
EBITDA
1 |
49.14
|
163.8
|
144.8
|
678.1
|
1,396
|
403.4
|
EBIT
1 |
-52.61
|
53.8
|
30.93
|
554.5
|
1,268
|
267.7
|
Operating Margin
|
-4.46%
|
3.9%
|
2.28%
|
21.45%
|
36.03%
|
12.87%
|
Earnings before Tax (EBT)
1 |
-73.93
|
30.52
|
111.1
|
536.3
|
1,285
|
298.1
|
Net income
1 |
-61.06
|
21.51
|
94.82
|
379.6
|
870.9
|
211.1
|
Net margin
|
-5.18%
|
1.56%
|
6.98%
|
14.69%
|
24.74%
|
10.15%
|
EPS
2 |
-0.0720
|
0.0252
|
0.1113
|
0.4456
|
1.004
|
0.2420
|
Free Cash Flow
1 |
2.098
|
31.85
|
-267.8
|
96.95
|
406.5
|
391.2
|
FCF margin
|
0.18%
|
2.31%
|
-19.7%
|
3.75%
|
11.55%
|
18.81%
|
FCF Conversion (EBITDA)
|
4.27%
|
19.44%
|
-
|
14.3%
|
29.13%
|
97%
|
FCF Conversion (Net income)
|
-
|
148.08%
|
-
|
25.54%
|
46.68%
|
185.36%
|
Dividend per Share
|
-
|
-
|
0.0253
|
0.1629
|
0.2831
|
0.1180
|
Announcement Date
|
4/18/19
|
4/23/20
|
4/21/21
|
4/22/22
|
4/26/23
|
4/22/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
44
|
74
|
92.1
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
71.6
|
446
|
615
|
Leverage (Debt/EBITDA)
|
0.8949
x
|
0.4518
x
|
0.6358
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.1
|
31.8
|
-268
|
96.9
|
407
|
391
|
ROE (net income / shareholders' equity)
|
-5.16%
|
0.9%
|
5.8%
|
25%
|
45%
|
9.15%
|
ROA (Net income/ Total Assets)
|
-1.82%
|
1.87%
|
1.01%
|
16.4%
|
30%
|
5.69%
|
Assets
1 |
3,358
|
1,151
|
9,389
|
2,320
|
2,899
|
3,710
|
Book Value Per Share
2 |
1.490
|
1.520
|
1.630
|
2.050
|
2.770
|
2.810
|
Cash Flow per Share
2 |
0.0600
|
0.1900
|
0.1500
|
0.2700
|
0.3400
|
0.2000
|
Capex
1 |
77.6
|
240
|
216
|
213
|
262
|
318
|
Capex / Sales
|
6.58%
|
17.38%
|
15.88%
|
8.26%
|
7.44%
|
15.31%
|
Announcement Date
|
4/18/19
|
4/23/20
|
4/21/21
|
4/22/22
|
4/26/23
|
4/22/24
|
|
1st Jan change
|
Capi.
|
---|
| -21.09% | 127M | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +4.67% | 32.41B | | +6.59% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B | | -14.74% | 13.81B |
Other Commodity Chemicals
|